West Pharmaceutical Services Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$874,500	$872,300	$844,900	$805,000
Gross Profit	347,400	329,200	296,400	303,900
EBITDA	313,600	225,300	218,500	209,500
EBIT	267,700	179,100	173,900	162,500
Net Income	214,000	154,000	138,800	132,100
Net Change In Cash	874,500	872,300	844,900	805,000
Free Cash Flow	150,400	80,800	47,200	175,000
Cash	464,100	435,800	521,400	791,300
Basic Shares	70,800	71,300	72,400	72,700

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,073,700	$2,892,700	$2,951,100	$2,885,500
Gross Profit	1,103,300	1,002,200	1,132,700	1,138,900
EBITDA	770,600	743,800	844,100	808,100
EBIT	599,200	588,400	706,800	687,500
Net Income	493,700	492,700	593,400	585,900
Net Change In Cash	3,073,700	2,892,700	2,951,100	2,885,500
Cost of Revenue				142,200
Free Cash Flow	468,900	276,400	414,500	439,400
Cash	791,300	484,600	853,900	894,300
Basic Shares	72,700	73,700	75,300	75,800